Phase I Trial of Ribociclib in Combination With Everolimus and Dexamethasone in Children and Young Adults With Relapsed Acute Lymphoblastic Leukemia
Status: Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 17 Jan 2020
Price : $35 *
At a glance
- Drugs Dexamethasone (Primary) ; Everolimus (Primary) ; Ribociclib (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions; Pharmacokinetics
- 21 Oct 2019 Status changed from recruiting to active, no longer recruiting.
- 29 Jan 2019 Status changed from not yet recruiting to recruiting.
- 21 Nov 2018 New trial record